These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11316375)

  • 41. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients.
    González G; Desai R; Sofuoglu M; Poling J; Oliveto A; Gonsai K; Kosten TR
    Drug Alcohol Depend; 2007 Feb; 87(1):1-9. PubMed ID: 16930857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A double-blind randomized placebo-controlled study of the efficacy of the combined treatment with naltrexone and guanfacine for relapse prevention in opiate dependence].
    Krupitsky EM; Blokhina EA; Zvartau EE; Verbitskaya VE; Bushara EM; Tiurina AA; Palatkin VY; Yaroslavtseva TS; Burakov AM; Masalov DV; Romanova TN; Grininko AY; Sinha R; Kosten T
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):39-46. PubMed ID: 26525620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study).
    Morley KC; Kranzler HR; Luquin N; Baillie A; Shanahan M; Trent R; Teesson M; Haber PS
    Trials; 2018 Aug; 19(1):443. PubMed ID: 30115121
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness.
    Krupitsky E; Nunes EV; Ling W; Gastfriend DR; Memisoglu A; Silverman BL
    Addiction; 2013 Sep; 108(9):1628-37. PubMed ID: 23701526
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Naltrexone in the treatment of alcohol dependence.
    Volpicelli JR; Alterman AI; Hayashida M; O'Brien CP
    Arch Gen Psychiatry; 1992 Nov; 49(11):876-80. PubMed ID: 1345133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
    Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP
    Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence.
    Somoza EC; Winship D; Gorodetzky CW; Lewis D; Ciraulo DA; Galloway GP; Segal SD; Sheehan M; Roache JD; Bickel WK; Jasinski D; Watson DW; Miller SR; Somoza P; Winhusen T
    JAMA Psychiatry; 2013 Jun; 70(6):630-7. PubMed ID: 23575810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
    Collins ED; Kleber HD; Whittington RA; Heitler NE
    JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
    Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
    Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence.
    Shoptaw S; Heinzerling KG; Rotheram-Fuller E; Kao UH; Wang PC; Bholat MA; Ling W
    J Addict Dis; 2008; 27(1):13-23. PubMed ID: 18551884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone.
    Sullivan MA; Bisaga A; Glass A; Mishlen K; Pavlicova M; Carpenter KM; Mariani JJ; Levin FR; Nunes EV
    Drug Alcohol Depend; 2015 Feb; 147():122-9. PubMed ID: 25555621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medical treatments for opioid use disorder in Iran: a randomized, double-blind placebo-controlled comparison of buprenorphine/naloxone and naltrexone maintenance treatment.
    Mokri A; Chawarski MC; Taherinakhost H; Schottenfeld RS
    Addiction; 2016 May; 111(5):874-82. PubMed ID: 26639678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
    McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E
    Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence.
    Kampman KM; Lynch KG; Pettinati HM; Spratt K; Wierzbicki MR; Dackis C; O'Brien CP
    Drug Alcohol Depend; 2015 Oct; 155():105-10. PubMed ID: 26320827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial.
    Guardia J; Caso C; Arias F; Gual A; Sanahuja J; Ramírez M; Mengual I; Gonzalvo B; Segura L; Trujols J; Casas M
    Alcohol Clin Exp Res; 2002 Sep; 26(9):1381-7. PubMed ID: 12351933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relapse prevention treatment for cocaine dependence: group vs. individual format.
    Schmitz JM; Oswald LM; Jacks SD; Rustin T; Rhoades HM; Grabowski J
    Addict Behav; 1997; 22(3):405-18. PubMed ID: 9183510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progesterone effects on cocaine use in male cocaine users maintained on methadone: a randomized, double-blind, pilot study.
    Sofuoglu M; Poling J; Gonzalez G; Gonsai K; Oliveto A; Kosten TR
    Exp Clin Psychopharmacol; 2007 Oct; 15(5):453-60. PubMed ID: 17924779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Naltrexone and disulfiram in patients with alcohol dependence and current depression.
    Petrakis I; Ralevski E; Nich C; Levinson C; Carroll K; Poling J; Rounsaville B;
    J Clin Psychopharmacol; 2007 Apr; 27(2):160-5. PubMed ID: 17414239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use.
    Shoptaw S; Yang X; Rotheram-Fuller EJ; Hsieh YC; Kintaudi PC; Charuvastra VC; Ling W
    J Clin Psychiatry; 2003 Dec; 64(12):1440-8. PubMed ID: 14728105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mediators of telephone-based continuing care for alcohol and cocaine dependence.
    Mensinger JL; Lynch KG; TenHave TR; McKay JR
    J Consult Clin Psychol; 2007 Oct; 75(5):775-84. PubMed ID: 17907859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.